Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-06-22FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's generic combination of four amphetamine salt components under an Original Application (ANDA) for ADHD and narc…
-
FDA approval · 2012-06-14FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA page describes a supplemental application for Strattera (atomoxetine hydrochloride) by Eli Lilly. The submission status is AP.
-
FDA approval · 2012-05-02FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for FOCALIN XR by Sandoz Inc (dexmethylphenidate hydrochloride). The submission status indicates app…
-
FDA approval · 2012-03-27FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Teva’s generic combination of four amphetamine salts (dextroamphetamine saccharate, amphetam…
-
FDA approval · 2012-03-15FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' methylphenidate hydrochloride as a generic original-application product for the treatment of att…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-02-07FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a four-salt amphetamine combination (dextroamphetamine saccharate, amph…
-
FDA approval · 2011-12-01FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Original Application (Dr. Reddy's Laboratories Inc)
FDA approved the original application for a generic methylphenidate hydrochloride extended-release product (LA) from Dr. Reddy's Laboratorie…
-
FDA approval · 2011-10-25FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved Wilshire Pharmaceuticals' generic dextroamphetamine sulfate under an original ANDA. The product is intended for the same in…
-
FDA approval · 2011-06-08FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for INTUNIV (guanfacine) by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2011-04-21FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR filed by Sandoz Inc. The product contains dexmethylphenidate hydrochloride for th…
-
FDA approval · 2011-03-16FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2011-03-07FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) from Eli Lilly to update the labeling.
-
FDA approval · 2011-02-25FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for INTUNIV (guanfacine) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2011-01-26FDA Approved: CLONIDINE HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s clonidine hydrochloride generic under ANDA200300, authorizing its marketing as a generic a…
-
FDA approval · 2010-12-10FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for methylphenidate hydrochloride submitted by SpecGx LLC.
-
FDA approval · 2010-12-09FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) filed by Sandoz Inc.
-
FDA approval · 2010-12-09FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for methylphenidate by Sandoz Inc, resulting in an updated label for the product.
-
FDA approval · 2010-11-23FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) filed by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2010-11-15FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) filed by Sandoz Inc.
-
FDA approval · 2010-11-15FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) submitted by Sandoz Inc.
-
FDA approval · 2010-11-12FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a four-salt amphetamine product (dextroamphetamine saccharate, amphetam…
-
FDA approval · 2010-11-10FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) from Takeda Pharmaceuticals America.
-
FDA approval · 2010-10-18FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approved a supplemental application for the methylphenidate transdermal system (a patch) for ADHD, submitted by PADAGIS US LLC.
-
FDA approval · 2010-10-18FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for METHYLIN (methylphenidate hydrochloride) submitted by Shionogi Inc.
-
FDA approval · 2010-10-18FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for methylphenidate hydrochloride CD from Lannett Company, Inc. under NDA 021259, authorizing co…